Bee Venom vs Triple-Negative Breast Cancer: Why This Lab Study Matters

More than five years after its publication, a 2020 laboratory study on honeybee venom and breast cancer continues to draw attention as researchers seek new options for aggressive, hard-to-treat forms of the disease. While the findings remain preclinical and no human trials have begun, the work offers potential avenues for synthetic compounds that could one […]
The post Bee Venom vs Triple-Negative Breast Cancer: Why This Lab Study Matters appeared first on Dallas Express.
💡 AI analysis provides alternative perspectives on current events